United States Department of Veterans Affairs
R&D HOME » NEWS » RESEARCH_HIGHLIGHTS

Research Highlights

VA, NIH to fund $7 million in substance abuse studies

Effort to focus on troops, veterans of operations Enduring Freedom and Iraqi Freedom

September 13, 2009

 Troops in the Helmand Province in Afghanistan

Stress reaction—Troops serving in operations Enduring Freedom and Iraqi Freedom, such as these Marines conducting a nighttime patrol in Helmand province, Afghanistan, often face longer, multiple deployments and high exposure to stressors that can increase the risk of substance abuse disorders. These disorders commonly occur along with war-related problems such as PTSD, anxiety, depression, sleep disturbances, traumatic brain injury, and chronic pain. (Photo by Cpl. Artur Shvartsberg).

VA is collaborating with the National Institutes of Health to fund $7 million in research on problems related to the use of alcohol, tobacco and drugs—both prescription and illegal—among U.S. military personnel who have served in Iraq or Afghanistan.

"This is the first large-scale interagency effort on this topic," notes Theresa Gleason, PhD, a program manager with VA's Office of Research and Development. She says the initiative grew out of interagency meetings followed by a scientific conference held earlier this year. "We realized we could do more as a group to address these issues."

VA will partner with the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the National Cancer Institute on the initiative. Each agency will fund studies relevant to its particular mission. The focus will be on identifying the causes of substance use and abuse and improving screening, prevention and treatment.

A VA study appearing this month in the American Journal of Public Health found that of nearly 290,000 Iraq and Afghanistan veterans who were first seen in VA between 2002 and 2008, about seven percent had alcohol use disorders. Three percent had drug use disorders. Tobacco use was not addressed in the study, but statistics show that VA treats nearly 500,000 veterans each year for nicotine dependence. These issues often occur along with warrelated problems such as traumatic brain injury, posttraumatic stress disorder, pain, depression, anxiety, and sleep disturbances. Overall, the impact on individuals and families can be huge.

"Working in collaboration with key federal agencies, we hope to learn more about how to address the array of social and emotional problems caused by the trauma of war that bring so much pain to soldiers and their families," said NIDA Director Nora D. Volko, MD, in a press statement. "Even though they are no longer in combat, many of these brave men and women are now fighting substance addiction—another dangerous enemy."

NIAAA acting director Kenneth Warren, PhD, added: "The transition period as soldiers withdraw from battlefield stress and face the rigors of readjusting to life at home can be a critical turning point. This partnership will enhance our efforts to find solutions to the complex alcohol and substance abuse problems that plague our soldiers and their families."

VA and NIH officials estimate that about 20 studies will be funded through the initiative.

This article originally appeared in the September 2009 issue of VA Research Currents.